The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $75.06

Today's change+0.96 +1.30%
Updated October 19 2:34 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $75.06

Today's change+0.96 +1.30%
Updated October 19 2:34 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp up (U.S.)$0.96

CVS Health Corp is up today by (U.S.)$0.96 or 1.30% to (U.S.)$75.06. Over the last five days, shares have gained 1.73%, but are down 4.88% for the last year to date. Shares have underperformed the S&P 500 by 32.47% during the last year.

Key company metrics

  • Open(U.S.) $74.26
  • Previous close(U.S.) $74.10
  • High(U.S.) $75.14
  • Low(U.S.) $74.20
  • Bid / Ask(U.S.) $75.05 / (U.S.) $75.07
  • YTD % change-4.88%
  • Volume4,542,277
  • Average volume (10-day)8,440,996
  • Average volume (1-month)6,335,451
  • Average volume (3-month)5,745,536
  • 52-week range(U.S.) $69.30 to (U.S.) $88.58
  • Beta0.89
  • Trailing P/E14.96×
  • P/E 1 year forward12.61×
  • Forward PEG1.50×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.66%
  • Trailing EPS(U.S.) $5.02
Updated October 19 2:34 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.15%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue45,68544,51445,97144,615
Total other revenue--------
Total revenue45,68544,51445,97144,615
Gross profit6,9356,5807,6067,492
Total cost of revenue38,75037,93438,36537,123
Total operating expense43,56842,72142,97641,899
Selling / general / administrative4,8184,7874,6114,675
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0--0101
Other operating expenses, total--------
Operating income2,1171,7932,9952,716
Interest income (expense), net non-operating-251-258-248-258
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8631,5342,7532,463
Income after tax1,0979621,7071,542
Income tax, total7665721,046921
Net income1,0989521,7071,540
Total adjustments to net income-45-9-6
Net income before extra. items1,0979611,7071,541
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0939661,6981,535
Inc. avail. to common incl. extra. items1,0949571,6981,534
Diluted net income1,0949571,6981,534
Dilution adjustment--------
Diluted weighted average shares1,0241,0351,0701,073
Diluted EPS excluding extraordinary itemsvalue per share1.070.931.591.43
Dividends per sharevalue per share0.500.500.430.43
Diluted normalized EPSvalue per share1.070.931.591.49